SPONSORS & EXHIBITORS:
This conference presents CROs, CMOs, SMOs and other solution-provider firms with a unique opportunity to contribute to the intellectual content of the conference program; and to network with leading decision-makers and potential business-to-business partners. If your firm would benefit by having a platform to demonstrate your expertise, products or services, find out more about the sponsorship and expo opportunities at this conference. Contact:

Kellie Swanstrom, VP Business Development, iiBIG at 973-571-0867 or info@iibig.com

THANK YOU TO OUR SPONSORS:
	Thompson Hine LLP is one of the country's premier law firms and represents a wide range of successful business enterprises from around the world. The firm's Global Sourcing & Procurement Practice represents both buyers and providers of sourced services across multiple industries, including the biotech, life sciences and pharmaceutical industries. The firm's Life Sciences Practice Group represents clients in a wide range of business, technical and intellectual property matters, including pharmaceutical and clinical research and development endeavors, technology commercialization, and domestic and international clinical trials.
	Alpha Independent Review Board is a central IRB that provides complete IRB review services nationwide. We strive to provide exceptional customer service and are dedicated to protecting the rights and welfare of every study subject. For more information, please visit www.alphairb.com.
	Beardsworth – The Global CRO for Oncology & Complex Clinical Trials Beardsworth is a full service global CRO delivering business solutions for complex clinical trials in difficult therapeutic areas for 24 years. Our niche –oncology / oncology supportive care and vaccines. We have designed, managed, monitored, analyzed, and summarized trials from Phase 1 – 4 for over 50 oncology and oncology-related studies. In addition to our seasoned, dedicated clinical management staff, Beardsworth has regional monitors located throughout the United States and Canada and global capabilities through trusted alliances. Headquartered in Flemington, NJ, Beardsworth is a WBENC-certified, woman-owned business & registrant with CCR.
	D. Anderson & Company (DAC), an international patient recruitment and retention leader, is proud to have served the clinical trials industry for more than 18 years. Through our evolution as a niche SMO and CRO to a premier Patient Recruitment Organization, sophistication has become DAC’s signature. We emphasize strategy over tactics to provide unparalleled service. If you seek a patient recruitment provider who offers superior project management, customized services and creative acuity, look no further.
	eStudy Binder® is the industry's leading automated electronic Trial Master and Investigator Site File (eTMF-ISF), regulatory compliance and metadata integration solutions for clinical trials. We help customers accelerate drug development through innovation designed by industry users. Our global services enable life sciences companies to streamline workflow, save time and ensure compliance.
	Excend advises leading organizations in all areas of global outsourcing and localization. Excend provides personnel onsite both in the United States and in international markets to carry on management and quality control of its clients’ outsourced operations. Excend works closely with life sciences clients in private-sector, government, regulatory, and industry-specific organizations worldwide—with a particular focus on the regions of Latin America and North America. Please contact us at www.excend.com or 801-532-2268.
	Fountain Medical Development is a contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services for multinational clients conducting clinical research in China, HK, Taiwan and Korea. Our services include regulatory affairs, clinical operation, central laboratory and hospital based, CRO operated phase I center. The management team of Fountain has decades of combined experience working with the world's leading CRO's and drug developers. In the Asia CRO market, we fill the void of a service provider that balances high quality with moderate cost. Our extensive global experience in multiple therapeutic areas is unmatched by other local CRO's, and our lower operational cost allows us to pass significant savings on to our clients.
	McElroy Translation places 42 years of experience, extensive linguistic resources, and advanced business processes to work for every client. McElroy provides legal, technical, medical and business translation, as well as software and website localization. Our technology experts combine workflow and translation management systems to provide our clients with customized solutions.
	Medidata Solutions (www.mdsol.com) is committed to providing life science organizations the most advanced tools for planning and managing clinical trials, putting innovative technology and insightful data into researchers’ hands to help streamline the clinical trial process while helping accelerate the process of bringing life-enhancing treatments to market.
	Medpace is a global CRO, research-based drug development company led by top therapeutic and regulatory experts who are driven to further the advancement of pharmaceutical agents for use in cardiology, metabolism, and oncology. With clinical trial experience in 44 countries, Medpace has the reach and capability to conduct studies worldwide.
	MNX Global LifeSciences Logistics provides first flight global door to door cold chain transportation of vaccines, specimens, clinical drugs and clinical supplies as part of our worldwide clinical trial services. One of the pioneers of First Flight global transportation since the early 1980’s, MNX has developed a level of expertise that has allowed us to move seamlessly into time definite, temperature controlled international and domestic shipping. MNX is able to handle your clinical trial needs by building strong relationships and alliances around the world. From R&D to clinical trials to finished goods, MNX is providing a complete global fulfillment service.
	PharmaNet Development Group, a global drug development services company, provides expertise to the pharmaceutical, biotechnology, generic drug, and medical device industries. PharmaNet companies offer clinical development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs.
	PSI is a leading full-service CRO with offices across Europe and the Americas, specializing in clinical drug development in all major therapeutic areas. For more information on this industry-leading company go to: www.psi-cro.com
	Quorum Review was founded in 1992 and earned AAHRPP accreditation in 2006. In 2008, Quorum introduced the following new streamlining processes: 1 day turn-around for sites’ approvals North American Board to review Canadian Studies 3 times weekly board meetings New Phase I group created for speed and flexibility Daily Board meetings for amendments 1 time CV and audit submission Electronic Portal with all documents available Aggressive Phase IV Registry Pricing In-house “Fast-track” translations Review of Federally funded studies For more information on Quorum’s exciting array of expedited services please contact: Customer Relations at CustomerRelations@QuorumReview.com, www.QuorumReview.com
	For 25 years SciAn Services has provided contract research services to support the clinical development programs of the North American Biotech industry with: Strategic Consulting, Data Management, including EDC, Biostatistics, Medical Writing and Global Safety / SAE Management services. SciAn’s extensive experience over 605 studies in a wide range of therapeutic areas has resulted in SciAn being a leader in data quality and trial efficiency, and a respected advisor in all stages of clinical development. SciAn’s participation in the International Consortium on Anti-Virals, international and large multi-site regional clinical studies gives SciAn particular insight into the operational challenges of these studies.
	The Pioneers in Drug Development Costs Benchmarking & Analysis TTC, founded in 2001 by Dr. Harold Glass, the creator of clinical costs benchmarking databases, has their headquarters in Philadelphia, with offices in Chicago and London. With 5 distinctive database products, TTC has the largest current database of investigator site budgets from 60 countries. TTC combines a strong financial base, a global reach and an experienced team of customer focused professionals proud to serve the industry in the management of costs and speed of clinical trials. With nearly 100 clients who conduct over 75% of the clinical trials around the world, TTC stands ready to serve all companies with specific programs tailored to meet their customized requirements.